Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model

Duchenne muscular dystrophy (DMD) is a lethal disease caused by X-linked mutations in the dystrophin gene. Dystrophin deficiency results in progressive degeneration of cardiac, respiratory and skeletal muscles leading to premature death due to cardiopulmonary complications. Currently, no cure exists...

Descripción completa

Detalles Bibliográficos
Autores principales: Siemionow, Maria, Brodowska, Sonia, Langa, Paulina, Zalants, Kristina, Kozlowska, Katarzyna, Grau-Kazmierczak, Wictoria, Heydemann, Ahlke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385806/
https://www.ncbi.nlm.nih.gov/pubmed/35978142
http://dx.doi.org/10.1007/s00005-022-00656-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385806/
https://www.ncbi.nlm.nih.gov/pubmed/35978142
http://dx.doi.org/10.1007/s00005-022-00656-7

Ejemplares similares